Growth Metrics

Solesence (SLSN) EPS (Weighted Average and Diluted) (2017 - 2026)

Solesence filings provide 10 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.01 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed N/A to -$0.01 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.01, a 75.0% decrease, with the full-year FY2025 number at $0.02, down 71.43% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.01 in Q1 2026 for Solesence, up from -$0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.04 in Q3 2024 to a low of -$0.04 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.01 (2026), compared with a mean of -$0.01.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 300.0% in 2022 and later soared 300.0% in 2025.
  • Solesence's EPS (Weighted Average and Diluted) stood at -$0.04 in 2022, then increased by 0.0% to -$0.04 in 2023, then soared by 75.0% to -$0.01 in 2024, then crashed by 100.0% to -$0.02 in 2025, then soared by 50.0% to -$0.01 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.01 (Q1 2026), -$0.02 (Q3 2025), and $0.04 (Q2 2025) per Business Quant data.